Xponential Fitness To Acquire Weight Loss Clinic Lindora
The metabolic health clinic becomes Xponential’s 11th brand and solidifies the fitness franchisor’s entry into the broader wellness space
Xponential Fitness is acquiring Lindora, a metabolic health brand with clinics offering weight-loss medications, hormone replacement therapy and IV hydration. The deal, which adds to Xponential’s portfolio of ten boutique fitness offerings, represents a new opportunity for the franchisor in the holistic health and wellness arena.
The deal is expected to close in early 2024 and will see Lindora’s 31 clinics — 30 of which are in Southern California and one in Washington — become Xponential franchise locations. The boutique fitness franchisor confirms it will acquire all of Lindora’s intellectual property and plans to franchise the brand nationally and globally.
“This acquisition further solidifies Xponential’s leadership in identifying and incorporating the latest innovations in health and wellness,” said Anthony Geisler, founder and CEO of Xponential. “We have long admired Lindora’s integrated approach to metabolic health, effectively combining behavioral approaches with the most recent medical breakthroughs, from weight loss medications to hormone replacement therapy and IV hydration.”
Geisler added that Lindora complements Xponential’s existing brands and will help the boutique fitness franchise deliver on the increasing demand for a holistic approach to health. Last month, Geisler had indicated to Athletech News that the company was exploring adding an eleventh brand in the growing wellness space.
“Lindora is led by a veteran team, and we are looking forward to partnering with them to address some of the most critical and widespread health challenges facing the U.S. and beyond,” he said.
Colleen Lewis, CEO of Lindora, noted that the brand is thrilled to join Xponential, referring to the franchisor as an ideal partner as the holistic health and wellness brand enters its next phase of growth.
“This partnership will allow Lindora to become one of the first national brands in medical metabolic management, and we are energized to share what has been effective in delivering outstanding outcomes for our valued clients with people on a global scale,” Lewis said.
Fitness Industry Embraces Weight Loss
Although Xponential has cornered the boutique fitness market with leading brands such as Club Pilates, Pure Barre, and StretchLab, acquiring Lindora brings enormous promise, especially as consumers integrate GLP-1 weight-loss drugs into their wellness journeys.
Xponential isn’t alone in its strategy — not wanting to miss an opportunity in what analysts project to be a $100 billion market by 2030, fitness businesses are clamoring to offer weight-loss medications to their clients and members.
Life Time, an operator of fitness and health-focused luxury lifestyle country clubs, has begun piloting a Miora Longevity and Performance clinic at its Target Center club in Minneapolis. The clinic, which provides wellness therapies such as infrared saunas, peptides and hormone replacement therapy, also offers GLP-1 weight loss drugs. Life Time plans to expand the clinics to its 170-plus locations if the pilot clinic proves fruitful.
Beyond fitness studios, WeightWatchers, a household name for its points-based weight loss plan, also pivoted to the weight loss medication industry with the acquisition of Sequence earlier this year. Digital health platform Noom made a similar play in 2023 with the launch of Noom Med, pairing consumers with clinicians who may prescribe weight loss medication for those qualified.
